Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow
POLITICS
February 26, 20213 min read, 612 words

Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to followJohnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow

 and  in 
Published: February 26, 2021  |  3 min read, 612 words
By , (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted to recommend authorization of Johnson & Johnson’s one-dose COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.The FDA is likely to authoriz...
Johnson & Johnson COVID-19 vaccine backed by advisory panel, U.S. authorization to follow Read more

No article scores yet.

There are no critic or public scores for this article yet.
critic reviews: 0
public reviews: 0
No reviews

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.